APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antivirals

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antivirals Industry Growth and Trends Forecast to 2032

20 December 2025103 pages

Choose your research edition.

Industry ResearchAntivirals Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Antivirals Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Antivirals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antivirals Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antivirals Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Antivirals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antivirals include Teva Pharmaceutical Industries, Johnson & Johnson, Merck, Mylan, Gilead Sciences, GSK, AbbVie, F. Hoffmann-La Roche and Dr Reddy’s, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antivirals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antivirals market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antivirals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antivirals.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antivirals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antivirals Market by Company

Teva Pharmaceutical Industries

Johnson & Johnson

Merck

Mylan

Gilead Sciences

GSK

AbbVie

F. Hoffmann-La Roche

Dr Reddy’s

Cipla

Bristol-Myers-Squibb

Aurobindo Pharma

Antivirals Segment by Type

Generic

Branded

Antivirals Segment by Application

HIV

Influenza

Hepatitis

HSV

Antivirals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antivirals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antivirals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antivirals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antivirals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Generic Table 2. Major Company of Branded Table 3. Global Antivirals Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Antivirals Sales by Type (2021-2026) & (k tons) Table 5. Global Antivirals Sales Market Share in Volume by Type (2021-2026) Table 6. Global Antivirals Sales by Type (2021-2026) & (US$ Million) Table 7. Global Antivirals Sales Market Share in Value by Type (2021-2026) Table 8. Global Antivirals Price by Type (2021-2026) & (US$/ton) Table 9. Global Antivirals Sales by Type (2027-2032) & (k tons) Table 10. Global Antivirals Sales Market Share in Volume by Type (2027-2032) Table 11. Global Antivirals Sales by Type (2027-2032) & (US$ Million) Table 12. Global Antivirals Sales Market Share in Value by Type (2027-2032) Table 13. Global Antivirals Price by Type (2027-2032) & (US$/ton) Table 14. North America Antivirals Sales by Type (2021-2026) & (k tons) Table 15. North America Antivirals Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Antivirals Sales by Type (2021-2026) & (k tons) Table 17. Europe Antivirals Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Antivirals Sales by Type (2021-2026) & (k tons) Table 19. Asia-Pacific Antivirals Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Antivirals Sales by Type (2021-2026) & (k tons) Table 21. Latin America Antivirals Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Antivirals Sales by Type (2021-2026) & (k tons) Table 23. Middle East and Africa Antivirals Sales by Type (2021-2026) & (US$ Million) Table 24. Antivirals Industry Trends Table 25. Antivirals Industry Drivers Table 26. Antivirals Industry Opportunities and Challenges Table 27. Antivirals Industry Restraints Table 28. Global Antivirals Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Antivirals Revenue Market Share by Company (2021-2026) Table 30. Global Antivirals Sales by Company (2021-2026) & (k tons) Table 31. Global Antivirals Sales Share by Company (2021-2026) Table 32. Global Antivirals Market Price by Company (2021-2026) & (US$/ton) Table 33. Global Antivirals Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Antivirals Major Company Production Sites and Headquarters Table 35. Global Antivirals Company, Product Type & Application Table 36. Global Antivirals Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Antivirals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Antivirals Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Antivirals Sales by Region (2021-2026) & (k tons) Table 41. Global Antivirals Sales Market Share in Volume by Region (2021-2026) Table 42. Global Antivirals Sales by Region (2021-2026) & (US$ Million) Table 43. Global Antivirals Sales Market Share in Value by Region (2021-2026) Table 44. Global Antivirals Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 45. Global Antivirals Sales by Region (2027-2032) & (k tons) Table 46. Global Antivirals Sales Market Share in Volume by Region (2027-2032) Table 47. Global Antivirals Sales by Region (2027-2032) & (US$ Million) Table 48. Global Antivirals Sales Market Share in Value by Region (2027-2032) Table 49. Global Antivirals Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 50. Global Antivirals Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Antivirals Sales by Application (2021-2026) & (k tons) Table 52. Global Antivirals Sales Market Share in Volume by Application (2021-2026) Table 53. Global Antivirals Sales by Application (2021-2026) & (US$ Million) Table 54. Global Antivirals Sales Market Share in Value by Application (2021-2026) Table 55. Global Antivirals Price by Application (2021-2026) & (US$/ton) Table 56. Global Antivirals Sales by Application (2027-2032) & (k tons) Table 57. Global Antivirals Sales Market Share in Volume by Application (2027-2032) Table 58. Global Antivirals Sales by Application (2027-2032) & (US$ Million) Table 59. Global Antivirals Sales Market Share in Value by Application (2027-2032) Table 60. Global Antivirals Price by Application (2027-2032) & (US$/ton) Table 61. North America Antivirals Sales by Application (2021-2026) & (k tons) Table 62. North America Antivirals Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Antivirals Sales by Application (2021-2026) & (k tons) Table 64. Europe Antivirals Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Antivirals Sales by Application (2021-2026) & (k tons) Table 66. Asia-Pacific Antivirals Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Antivirals Sales by Application (2021-2026) & (k tons) Table 68. Latin America Antivirals Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Antivirals Sales by Application (2021-2026) & (k tons) Table 70. Middle East and Africa Antivirals Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceutical Industries Company Information Table 72. Teva Pharmaceutical Industries Business Overview Table 73. Teva Pharmaceutical Industries Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Industries Antivirals Product Portfolio Table 75. Teva Pharmaceutical Industries Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Johnson & Johnson Antivirals Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Merck Antivirals Product Portfolio Table 85. Merck Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Mylan Antivirals Product Portfolio Table 90. Mylan Recent Development Table 91. Gilead Sciences Company Information Table 92. Gilead Sciences Business Overview Table 93. Gilead Sciences Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. Gilead Sciences Antivirals Product Portfolio Table 95. Gilead Sciences Recent Development Table 96. GSK Company Information Table 97. GSK Business Overview Table 98. GSK Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 99. GSK Antivirals Product Portfolio Table 100. GSK Recent Development Table 101. AbbVie Company Information Table 102. AbbVie Business Overview Table 103. AbbVie Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 104. AbbVie Antivirals Product Portfolio Table 105. AbbVie Recent Development Table 106. F. Hoffmann-La Roche Company Information Table 107. F. Hoffmann-La Roche Business Overview Table 108. F. Hoffmann-La Roche Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 109. F. Hoffmann-La Roche Antivirals Product Portfolio Table 110. F. Hoffmann-La Roche Recent Development Table 111. Dr Reddy’s Company Information Table 112. Dr Reddy’s Business Overview Table 113. Dr Reddy’s Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 114. Dr Reddy’s Antivirals Product Portfolio Table 115. Dr Reddy’s Recent Development Table 116. Cipla Company Information Table 117. Cipla Business Overview Table 118. Cipla Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 119. Cipla Antivirals Product Portfolio Table 120. Cipla Recent Development Table 121. Bristol-Myers-Squibb Company Information Table 122. Bristol-Myers-Squibb Business Overview Table 123. Bristol-Myers-Squibb Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 124. Bristol-Myers-Squibb Antivirals Product Portfolio Table 125. Bristol-Myers-Squibb Recent Development Table 126. Aurobindo Pharma Company Information Table 127. Aurobindo Pharma Business Overview Table 128. Aurobindo Pharma Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 129. Aurobindo Pharma Antivirals Product Portfolio Table 130. Aurobindo Pharma Recent Development Table 131. North America Antivirals Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 132. North America Antivirals Sales by Country (2021-2026) & (k tons) Table 133. North America Antivirals Sales Market Share by Country (2021-2026) Table 134. North America Antivirals Sales Forecast by Country (2027-2032) & (k tons) Table 135. North America Antivirals Sales Market Share Forecast by Country (2027-2032) Table 136. North America Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Antivirals Market Share by Country (2021-2026) Table 139. North America Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Antivirals Market Share Forecast by Country (2027-2032) Table 141. Europe Antivirals Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 142. Europe Antivirals Sales by Country (2021-2026) & (k tons) Table 143. Europe Antivirals Sales Market Share by Country (2021-2026) Table 144. Europe Antivirals Sales Forecast by Country (2027-2032) & (k tons) Table 145. Europe Antivirals Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Antivirals Market Share by Country (2021-2026) Table 149. Europe Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Antivirals Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Antivirals Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Antivirals Sales by Country (2021-2026) & (k tons) Table 153. Asia-Pacific Antivirals Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Antivirals Sales Forecast by Country (2027-2032) & (k tons) Table 155. Asia-Pacific Antivirals Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Antivirals Market Share by Country (2021-2026) Table 159. Asia-Pacific Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Antivirals Market Share Forecast by Country (2027-2032) Table 161. Latin America Antivirals Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 162. Latin America Antivirals Sales by Country (2021-2026) & (k tons) Table 163. Latin America Antivirals Sales Market Share by Country (2021-2026) Table 164. Latin America Antivirals Sales Forecast by Country (2027-2032) & (k tons) Table 165. Latin America Antivirals Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Antivirals Market Share by Country (2021-2026) Table 169. Latin America Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Antivirals Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Antivirals Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Antivirals Sales by Country (2021-2026) & (k tons) Table 173. Middle East and Africa Antivirals Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Antivirals Sales Forecast by Country (2027-2032) & (k tons) Table 175. Middle East and Africa Antivirals Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Antivirals Market Share by Country (2021-2026) Table 179. Middle East and Africa Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Antivirals Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Antivirals Distributors List Table 184. Antivirals Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Antivirals Image Figure 2. Global Antivirals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antivirals Market Size (2021-2032) & (US$ Million) Figure 4. Global Antivirals Sales (2021-2032) & (k tons) Figure 5. Generic Image Figure 6. Global Generic Sales YoY Growth (2021-2032) & (k tons) Figure 7. Branded Image Figure 8. Global Branded Sales YoY Growth (2021-2032) & (k tons) Figure 9. Global Antivirals Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Antivirals Market Share by Type 2025 VS 2032 Figure 11. North America Antivirals Sales Market Share in Volume by Type in 2025 Figure 12. North America Antivirals Sales Market Share in Value by Type in 2025 Figure 13. Europe Antivirals Sales Market Share in Volume by Type in 2025 Figure 14. Europe Antivirals Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Antivirals Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Antivirals Sales Market Share in Value by Type in 2025 Figure 17. Latin America Antivirals Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Antivirals Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Antivirals Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Antivirals Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Antivirals Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. HIV Image Figure 24. Global HIV Sales YoY Growth (2021-2032) & (k tons) Figure 25. Influenza Image Figure 26. Global Influenza Sales YoY Growth (2021-2032) & (k tons) Figure 27. Hepatitis Image Figure 28. Global Hepatitis Sales YoY Growth (2021-2032) & (k tons) Figure 29. HSV Image Figure 30. Global HSV Sales YoY Growth (2021-2032) & (k tons) Figure 31. Global Antivirals Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Antivirals Market Share by Application 2025 VS 2032 Figure 33. North America Antivirals Sales Market Share in Volume by Application in 2025 Figure 34. North America Antivirals Sales Market Share in Value by Application in 2025 Figure 35. Europe Antivirals Sales Market Share in Volume by Application in 2025 Figure 36. Europe Antivirals Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Antivirals Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Antivirals Sales Market Share in Value by Application in 2025 Figure 39. Latin America Antivirals Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Antivirals Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Antivirals Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Antivirals Sales Market Share in Value by Application in 2025 Figure 43. North America Antivirals Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 44. North America Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antivirals Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 48. Europe Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antivirals Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. Asia-Pacific Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antivirals Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Latin America Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antivirals Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Middle East and Africa Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Antivirals Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Antivirals Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Generic
  • Branded
Applications
  • HIV
  • Influenza
  • Hepatitis
  • HSV
Companies covered
  • Teva Pharmaceutical Industries
  • Johnson & Johnson
  • Merck
  • Mylan
  • Gilead Sciences
  • GSK
  • AbbVie
  • F. Hoffmann-La Roche
  • Dr Reddy’s
  • Cipla
  • Bristol-Myers-Squibb
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antivirals Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antivirals Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antivirals Market by Type
  6. 1.3.1 Generic
  7. 1.3.2 Branded
  8. 1.4 Global Antivirals Market Size by Type
  9. 1.4.1 Global Antivirals Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Antivirals Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Antivirals Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Antivirals Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Antivirals Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Antivirals Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Antivirals Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Antivirals Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antivirals Industry Trends
  2. 2.2 Antivirals Industry Drivers
  3. 2.3 Antivirals Industry Opportunities and Challenges
  4. 2.4 Antivirals Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antivirals Revenue (2021-2026)
  2. 3.2 Global Top Players by Antivirals Sales (2021-2026)
  3. 3.3 Global Top Players by Antivirals Price (2021-2026)
  4. 3.4 Global Antivirals Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antivirals Major Company Production Sites & Headquarters
  6. 3.6 Global Antivirals Company, Product Type & Application
  7. 3.7 Global Antivirals Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antivirals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antivirals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antivirals Tier 1, Tier 2, and Tier 3
4 Antivirals Regional Status and Outlook
  1. 4.1 Global Antivirals Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antivirals Historic Market Size by Region
  3. 4.2.1 Global Antivirals Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antivirals Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antivirals Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antivirals Forecasted Market Size by Region
  7. 4.3.1 Global Antivirals Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antivirals Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antivirals Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antivirals by Application
  1. 5.1 Antivirals Market by Application
  2. 5.1.1 HIV
  3. 5.1.2 Influenza
  4. 5.1.3 Hepatitis
  5. 5.1.4 HSV
  6. 5.2 Global Antivirals Market Size by Application
  7. 5.2.1 Global Antivirals Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Antivirals Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Antivirals Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Antivirals Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Antivirals Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Antivirals Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Antivirals Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Antivirals Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Antivirals Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Antivirals Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Antivirals Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Antivirals Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Antivirals Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Antivirals Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Antivirals Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Gilead Sciences
  26. 6.5.1 Gilead Sciences Company Information
  27. 6.5.2 Gilead Sciences Business Overview
  28. 6.5.3 Gilead Sciences Antivirals Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gilead Sciences Antivirals Product Portfolio
  30. 6.5.5 Gilead Sciences Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Antivirals Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Antivirals Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Antivirals Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AbbVie Antivirals Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 F. Hoffmann-La Roche
  44. 6.8.1 F. Hoffmann-La Roche Company Information
  45. 6.8.2 F. Hoffmann-La Roche Business Overview
  46. 6.8.3 F. Hoffmann-La Roche Antivirals Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 F. Hoffmann-La Roche Antivirals Product Portfolio
  48. 6.8.5 F. Hoffmann-La Roche Recent Developments
  49. 6.9 Dr Reddy’s
  50. 6.9.1 Dr Reddy’s Company Information
  51. 6.9.2 Dr Reddy’s Business Overview
  52. 6.9.3 Dr Reddy’s Antivirals Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dr Reddy’s Antivirals Product Portfolio
  54. 6.9.5 Dr Reddy’s Recent Developments
  55. 6.10 Cipla
  56. 6.10.1 Cipla Company Information
  57. 6.10.2 Cipla Business Overview
  58. 6.10.3 Cipla Antivirals Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cipla Antivirals Product Portfolio
  60. 6.10.5 Cipla Recent Developments
  61. 6.11 Bristol-Myers-Squibb
  62. 6.11.1 Bristol-Myers-Squibb Company Information
  63. 6.11.2 Bristol-Myers-Squibb Business Overview
  64. 6.11.3 Bristol-Myers-Squibb Antivirals Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bristol-Myers-Squibb Antivirals Product Portfolio
  66. 6.11.5 Bristol-Myers-Squibb Recent Developments
  67. 6.12 Aurobindo Pharma
  68. 6.12.1 Aurobindo Pharma Company Information
  69. 6.12.2 Aurobindo Pharma Business Overview
  70. 6.12.3 Aurobindo Pharma Antivirals Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Aurobindo Pharma Antivirals Product Portfolio
  72. 6.12.5 Aurobindo Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Antivirals Sales by Country
  2. 7.1.1 North America Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antivirals Sales by Country (2021-2026)
  4. 7.1.3 North America Antivirals Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antivirals Market Size by Country
  6. 7.2.1 North America Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antivirals Market Size by Country (2021-2026)
  8. 7.2.3 North America Antivirals Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antivirals Sales by Country
  2. 8.1.1 Europe Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antivirals Sales by Country (2021-2026)
  4. 8.1.3 Europe Antivirals Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antivirals Market Size by Country
  6. 8.2.1 Europe Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antivirals Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antivirals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antivirals Sales by Country
  2. 9.1.1 Asia-Pacific Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antivirals Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antivirals Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antivirals Market Size by Country
  6. 9.2.1 Asia-Pacific Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antivirals Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antivirals Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antivirals Sales by Country
  2. 10.1.1 South America Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antivirals Sales by Country (2021-2026)
  4. 10.1.3 South America Antivirals Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antivirals Market Size by Country
  6. 10.2.1 South America Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antivirals Market Size by Country (2021-2026)
  8. 10.2.3 South America Antivirals Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antivirals Sales by Country
  2. 11.1.1 Middle East and Africa Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antivirals Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antivirals Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antivirals Market Size by Country
  6. 11.2.1 Middle East and Africa Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antivirals Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antivirals Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antivirals Value Chain Analysis
  2. 12.1.1 Antivirals Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antivirals Production Mode & Process
  7. 12.2 Antivirals Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antivirals Distributors
  10. 12.2.3 Antivirals Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst